Hutch News
New HIV vaccine trial to launch in U.S., Latin America and Europe
‘Mosaico’ will enroll 3,800 transgender people and men who have sex with men
Engineering vaccine-like protection without a vaccine
CRISPR gene-editing used on antibody-making B cells
Increased racial and ethnic minority participation in HIV vaccine trials
From the HIV Vaccine Trials Network, Vaccine and Infectious Disease Division
Fred Hutch’s Dr. Adam Dingens a 2019 Weintraub Award recipient
He is among 13 graduate students selected for this prestigious award in biological sciences
Scientists strategize to stop HIV infections, work toward cure
A hot topic for a big scientific conference convening in Seattle
Cutting-edge approach maps HIV's escape routes
Atlas of immune-evading HIV mutations could inform design of new treatments, vaccines
Modified HIV immunogens engage neutralizing antibody precursors
From the Stamatatos lab, Vaccine and Infectious Disease Division
'Cautiously optimistic about HIV vaccines'
A conversation in advance of World AIDS Day with pioneering HIV researcher Dr. Larry Corey
Wild-type vs. modification: which is better?
From Stamatatos Laboratory, Vaccine and Infectious Disease Division
Computational biologist Dr. Raphael Gottardo receives 2018 Mortimer Spiegelman Award
American Public Health Association recognizes Fred Hutch researcher for his contributions to health statistics biology
HIV researcher Cassandra Simonich receives 2018 Graduate School Medal from University of Washington
Award honors her contributions to research and dedication to improving the lives of medically underserved populations
The pride of Fred Hutch
HIV Vaccine Trials Network veteran Steven Wakefield named a grand marshal in Seattle Pride Parade
The interplay between antibodies and T cells in HIV risk
From the HVTN and Vaccine and Infectious Disease Division
25 powerful years of HIV research
Longstanding Mombasa Cohort helps answer questions about HIV risk and transmission
Meet Peru's HIV superhero
By finding a better way to prevent HIV, Dr. Jorge Sanchez aims to help end his country’s AIDS epidemic
10 highlights of Fred Hutch science in 2017
A look back at notable discoveries in cancer immunotherapy, HIV prevention and more
New HIV vaccine study launched for World AIDS Day
As lights around the world glow red today, Fred Hutch-based researchers lead global effort to end the pandemic
Insights from infants could inform HIV vaccine design
Dr. Julie Overbaugh mines decades-old samples to find new clues to effective immune responses to HIV
Enlisting the microbiome in the quest for an AIDS vaccine
We now know that microbial communities, especially in our guts, profoundly affect immune response
Two is better than one
McElrath Laboratory, Vaccine and Infectious Disease Division
Understanding HIV’s evolutionary past — and future
Studies of how the virus evolved and how it might change down the road could help researchers develop vaccines or cures for the infection
Relatives of germinal center T cells move to the blood
From the McElrath Laboratory, Vaccine and Infectious Disease Division
Community-building leads to record enrollment in HIV prevention study
Fighting the stigma of HIV among communities of color takes trust — and time
HIV superinfection may inform vaccine design
From the Overbaugh Lab, Human Biology Division